↓ Skip to main content

Cochrane Database of Systematic Reviews

Febuxostat for treating chronic gout

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

blogs
1 blog
twitter
11 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
168 Mendeley
Title
Febuxostat for treating chronic gout
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd008653.pub2
Pubmed ID
Authors

Jean H Tayar, Maria Angeles Lopez‐Olivo, Maria E Suarez‐Almazor

Abstract

Gout is the most common inflammatory arthritis in men over 40 years and has an increasing prevalence among postmenopausal women. Lowering serum uric acid levels remains one of the primary goals in the treatment of chronic gout. In clinical trials, febuxostat has been shown to be effective in lowering serum uric acid levels to < 6.0 mg/dL.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 168 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
United Kingdom 1 <1%
Italy 1 <1%
Denmark 1 <1%
Unknown 163 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 18%
Student > Bachelor 28 17%
Researcher 18 11%
Student > Ph. D. Student 15 9%
Student > Postgraduate 10 6%
Other 15 9%
Unknown 52 31%
Readers by discipline Count As %
Medicine and Dentistry 58 35%
Nursing and Health Professions 11 7%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Social Sciences 7 4%
Psychology 6 4%
Other 17 10%
Unknown 60 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2020.
All research outputs
#2,266,417
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#4,664
of 11,499 outputs
Outputs of similar age
#15,226
of 192,725 outputs
Outputs of similar age from Cochrane database of systematic reviews
#93
of 238 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 238 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.